In vivo PET imaging and biodistributionstudies further validated its ability to selectively detect TfR1 expression.In HT29 tumor-bearing mice, PET scans enabled rapid visualizationof TfR1-positive tumors within 30 min postinjection, with substantiallyhigher tracer accumulation relative to LOVO tumors. Here, TFRC is linked to neoplasm.